Jehovah’s Witnesses Update Blood Component Policy to Allow Individual Conscience Decisions

Members of Jehovah’s Witnesses may now individually decide whether to accept or donate red cells, white cells, plasma, or platelets, marking a significant shift in the group’s long-standing policy on blood use. This change, announced by the Governing Body on 18 September 2026, allows for greater flexibility in medical treatment decisions while maintaining the prohibition on whole-blood transfusions. The decision reflects a broader evolution in the organization’s approach to blood-related practices, as it acknowledges that the Bible does not specifically address the use of blood components.

The adjustment comes as the second major revision of the Witnesses’ blood policy this year. In March 2026, the organization permitted members to decide whether to have their own blood collected, stored, and returned to them during medical or surgical procedures. This change, along with the current one, underscores a growing emphasis on individual conscience within the group’s medical guidelines.

Previously, Jehovah’s Witnesses rejected the four primary blood components—red cells, white cells, plasma, and platelets—while allowing the acceptance of certain fractions derived from blood, such as proteins and clotting factors. The new policy removes this distinction, granting members the right to make personal choices regarding these components. The Governing Body emphasized that congregations should not interfere in individual decisions or judge members for their choices, reinforcing the principle of personal responsibility within the faith.

The updated policy aligns with the organization’s teaching that blood is sacred, based on biblical instructions to “abstain from blood.” However, it acknowledges that the Bible does not explicitly address the use of blood components, leaving room for individual interpretation. Members are still instructed not to accept whole blood, donate blood for whole-blood transfusions, or consume blood, maintaining the core tenets of the faith.

The practical implications of this change could be substantial. Modern transfusion medicine often separates donated blood into components to meet specific patient needs. Red cells restore oxygen-carrying capacity, platelets help control bleeding, and plasma provides proteins involved in clotting. White-cell transfusions are less common and used in specialized circumstances. With this policy shift, a Witness patient may now consider treatments that previously conflicted with the religion’s rules, though not all members will accept every component.

Hospitals and medical professionals should be aware of this change to ensure that patients’ preferences are respected. While some members may continue to reject all blood-derived products, others may accept certain components while declining others. This policy adjustment reflects a nuanced approach to balancing religious principles with modern medical practices, as outlined in the organization’s updated guidance.

Source: Read the original report